Anti-HTR7 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22063; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-HTR7 Polyclonal Antibody – A Powerful Tool for Studying Serotonin Receptor Activity
The Anti-HTR7 Polyclonal Antibody is a highly specific and sensitive tool for studying serotonin receptor activity. This antibody targets the HTR7 receptor, also known as the 5-HT7 receptor, which is a G protein-coupled receptor that plays a crucial role in the regulation of serotonin signaling.
With the growing importance of serotonin in various physiological and pathological processes, the Anti-HTR7 Polyclonal Antibody has become an essential tool for researchers in the fields of neuroscience, psychiatry, and pharmacology. This antibody is highly versatile and can be used in a wide range of applications, making it an ideal choice for any study involving serotonin receptors.
The HTR7 receptor is primarily found in the central nervous system, where it is involved in the regulation of various functions, including mood, cognition, sleep, and pain perception. This receptor is also expressed in other tissues, such as the heart, gastrointestinal tract, and immune cells, indicating its involvement in a wide range of physiological processes.
The Anti-HTR7 Polyclonal Antibody has been extensively used in various research studies to investigate the role of the HTR7 receptor in different physiological and pathological processes. Some of the main applications of this antibody include:
1. Serotonin receptor signaling: The HTR7 receptor is a key player in serotonin signaling, and this antibody can be used to study the receptor’s activation and downstream signaling pathways.
2. Drug development: The Anti-HTR7 Polyclonal Antibody has been used to evaluate the efficacy and specificity of potential drugs targeting the HTR7 receptor. This antibody can also be used in drug screening assays to identify novel compounds that modulate HTR7 activity.
3. Neurological disorders: Dysregulation of serotonin signaling has been linked to various neurological disorders, such as depression, anxiety, and schizophrenia. The Anti-HTR7 Polyclonal Antibody can be used to investigate the role of the HTR7 receptor in these disorders and potentially identify new therapeutic targets.
The Anti-HTR7 Polyclonal Antibody has been successfully used in a variety of experimental settings, including:
1. Immunohistochemistry: This antibody has been used for immunohistochemical staining of tissue sections to visualize the distribution and localization of the HTR7 receptor.
2. Western blotting: The Anti-HTR7 Polyclonal Antibody has been used in western blotting to detect the expression of the HTR7 receptor in different tissues and cell lines.
3. Flow cytometry: This antibody has been used in flow cytometry to analyze the expression of the HTR7 receptor on the surface of cells.
In conclusion, the Anti-HTR7 Polyclonal Antibody is a highly specific and sensitive tool for studying the HTR7 receptor. Its versatility and wide range of applications make it a valuable asset for any research project involving serotonin receptors. Choose this antibody for reliable and accurate results in your experiments.
ProteoGenix catalogue number ARO-A22063. For research use only.
Target: 5-hydroxytryptamine receptor 7; 5-HT-7; 5-HT7; 5-HT-X; Serotonin receptor 7; HTR7; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 7; 5-HT-7; 5-HT7; 5-HT-X; Serotonin receptor 7; HTR7 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
